Harshabad Singh, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Barrett Esophagus | 2 | 2021 | 494 | 1.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2023 | 1636 | 1.110 |
Why?
|
fms-Like Tyrosine Kinase 3 | 3 | 2011 | 491 | 0.900 |
Why?
|
Pancreatic Neoplasms | 7 | 2023 | 5263 | 0.820 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 146 | 0.790 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2023 | 648 | 0.720 |
Why?
|
Adenocarcinoma | 5 | 2023 | 6364 | 0.610 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 665 | 0.590 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 634 | 0.570 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 196 | 0.500 |
Why?
|
Colorectal Neoplasms | 3 | 2024 | 6773 | 0.480 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2417 | 0.470 |
Why?
|
Stomach Neoplasms | 1 | 2023 | 1332 | 0.460 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1692 | 0.450 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1660 | 0.440 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.430 |
Why?
|
Genes, ras | 1 | 2015 | 690 | 0.430 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2014 | 314 | 0.410 |
Why?
|
Mutation | 7 | 2023 | 29786 | 0.410 |
Why?
|
Metaplasia | 2 | 2021 | 313 | 0.370 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2014 | 627 | 0.370 |
Why?
|
ras Proteins | 1 | 2015 | 1060 | 0.360 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2010 | 236 | 0.340 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2242 | 0.320 |
Why?
|
Stem Cells | 1 | 2021 | 3567 | 0.310 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11525 | 0.270 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5534 | 0.260 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2011 | 3524 | 0.260 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1340 | 0.250 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2016 | 2249 | 0.230 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1832 | 0.210 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1620 | 0.210 |
Why?
|
Inflammation | 1 | 2022 | 10637 | 0.210 |
Why?
|
Transcription Factors | 1 | 2021 | 12207 | 0.200 |
Why?
|
Graft Rejection | 1 | 2014 | 4397 | 0.200 |
Why?
|
SOX9 Transcription Factor | 1 | 2021 | 146 | 0.190 |
Why?
|
Anus Neoplasms | 1 | 2024 | 332 | 0.180 |
Why?
|
Leucovorin | 1 | 2021 | 628 | 0.180 |
Why?
|
Immunohistochemistry | 2 | 2024 | 11366 | 0.160 |
Why?
|
Neutropenia | 1 | 2023 | 895 | 0.150 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1758 | 0.150 |
Why?
|
Fluorouracil | 1 | 2021 | 1619 | 0.140 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2016 | 79 | 0.140 |
Why?
|
Epigenomics | 1 | 2021 | 903 | 0.130 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1376 | 0.130 |
Why?
|
Hypertension, Malignant | 1 | 2014 | 19 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 990 | 0.120 |
Why?
|
Humans | 24 | 2024 | 744366 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.120 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2014 | 110 | 0.120 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.110 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4185 | 0.110 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2418 | 0.100 |
Why?
|
Cell Lineage | 1 | 2021 | 2504 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1587 | 0.100 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2086 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4554 | 0.100 |
Why?
|
Inverted Repeat Sequences | 1 | 2010 | 61 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2182 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 295 | 0.090 |
Why?
|
Tandem Repeat Sequences | 1 | 2011 | 185 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2011 | 6896 | 0.090 |
Why?
|
Aged | 5 | 2023 | 163288 | 0.090 |
Why?
|
Male | 10 | 2023 | 350115 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2725 | 0.080 |
Why?
|
Subclavian Artery | 1 | 2009 | 130 | 0.080 |
Why?
|
Middle Aged | 6 | 2023 | 213390 | 0.080 |
Why?
|
Prognosis | 3 | 2023 | 29060 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2014 | 804 | 0.080 |
Why?
|
Leukemia, Myeloid | 1 | 2011 | 707 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4034 | 0.080 |
Why?
|
Aortic Coarctation | 1 | 2009 | 281 | 0.070 |
Why?
|
Fibrinogen | 1 | 2010 | 894 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16367 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 63107 | 0.070 |
Why?
|
Survival Rate | 2 | 2011 | 12788 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 21696 | 0.070 |
Why?
|
Female | 8 | 2023 | 380193 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2124 | 0.070 |
Why?
|
Transplantation, Homologous | 1 | 2014 | 4777 | 0.070 |
Why?
|
Cell Differentiation | 2 | 2021 | 11486 | 0.070 |
Why?
|
Mice | 4 | 2023 | 81201 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 857 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2291 | 0.060 |
Why?
|
Vascular Malformations | 1 | 2009 | 454 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2504 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 111 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2024 | 77460 | 0.050 |
Why?
|
Animals | 5 | 2023 | 168768 | 0.050 |
Why?
|
Adult | 5 | 2021 | 214052 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 200 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 159 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3590 | 0.050 |
Why?
|
Signal Transduction | 2 | 2015 | 23404 | 0.050 |
Why?
|
Deoxycytidine | 1 | 2023 | 826 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7914 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39052 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2016 | 57776 | 0.040 |
Why?
|
Young Adult | 3 | 2016 | 56429 | 0.040 |
Why?
|
Risk | 1 | 2010 | 9688 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10252 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 602 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13693 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1837 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2023 | 8432 | 0.030 |
Why?
|
United States | 1 | 2024 | 69872 | 0.030 |
Why?
|
Paclitaxel | 1 | 2023 | 1708 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1915 | 0.030 |
Why?
|
Prospective Studies | 2 | 2024 | 53290 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6313 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6621 | 0.030 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2014 | 131 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2727 | 0.030 |
Why?
|
Medical Oncology | 1 | 2023 | 2267 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 13882 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7294 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 452 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2011 | 659 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12961 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5717 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10483 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21833 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2513 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1265 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1443 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 40559 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 19233 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9724 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16690 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18034 | 0.010 |
Why?
|